BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28360196)

  • 1. Epithelial chemokine CXCL14 synergizes with CXCL12
    Collins PJ; McCully ML; Martínez-Muñoz L; Santiago C; Wheeldon J; Caucheteux S; Thelen S; Cecchinato V; Laufer JM; Purvanov V; Monneau YR; Lortat-Jacob H; Legler DF; Uguccioni M; Thelen M; Piguet V; Mellado M; Moser B
    FASEB J; 2017 Jul; 31(7):3084-3097. PubMed ID: 28360196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL14 is no direct modulator of CXCR4.
    Otte M; Kliewer A; Schütz D; Reimann C; Schulz S; Stumm R
    FEBS Lett; 2014 Dec; 588(24):4769-75. PubMed ID: 25451233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis.
    Hara T; Tanegashima K
    Biomol Concepts; 2014 May; 5(2):167-73. PubMed ID: 25372750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems.
    Kouzeli A; Collins PJ; Metzemaekers M; Meyrath M; Szpakowska M; Artinger M; Struyf S; Proost P; Chevigne A; Legler DF; Eberl M; Moser B
    Front Immunol; 2020; 11():561404. PubMed ID: 33123134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis.
    Tanegashima K; Suzuki K; Nakayama Y; Tsuji K; Shigenaga A; Otaka A; Hara T
    FEBS Lett; 2013 Jun; 587(12):1731-5. PubMed ID: 23669361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimeric peptides of the C-terminal region of CXCL14 function as CXCL12 inhibitors.
    Tanegashima K; Tsuji K; Suzuki K; Shigenaga A; Otaka A; Hara T
    FEBS Lett; 2013 Nov; 587(23):3770-5. PubMed ID: 24161674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
    Tu CC; Arnolds KL; O'Connor CM; Spencer JV
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine CXCL14 mediates platelet function and migration via direct interaction with CXCR4.
    Witte A; Rohlfing AK; Dannenmann B; Dicenta V; Nasri M; Kolb K; Sudmann J; Castor T; Rath D; Borst O; Skokowa J; Gawaz M
    Cardiovasc Res; 2021 Feb; 117(3):903-917. PubMed ID: 32239134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine CXCL12 induces binding of ferritin heavy chain to the chemokine receptor CXCR4, alters CXCR4 signaling, and induces phosphorylation and nuclear translocation of ferritin heavy chain.
    Li R; Luo C; Mines M; Zhang J; Fan GH
    J Biol Chem; 2006 Dec; 281(49):37616-27. PubMed ID: 17056593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL14-CXCR4 and CXCL12-CXCR4 Axes May Play Important Roles in the Unique Invasion Process of Endometrioid Carcinoma With MELF-Pattern Myoinvasion.
    Kojiro-Sanada S; Yasuda K; Nishio S; Ogasawara S; Akiba J; Ushijima K; Yano H
    Int J Gynecol Pathol; 2017 Nov; 36(6):530-539. PubMed ID: 28277316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative expression pattern analysis of the highly conserved chemokines SDF1 and CXCL14 during amniote embryonic development.
    García-Andrés C; Torres M
    Dev Dyn; 2010 Oct; 239(10):2769-77. PubMed ID: 21038449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X4 HIV-1 induces neuroblastoma cell death by interference with CXCL12/CXCR4 interaction.
    Hatse S; Bridger G; de Clercq E; Schols D
    Cell Mol Biol (Noisy-le-grand); 2003; 49 Online Pub():OL443-52. PubMed ID: 14995074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
    Guo L; Cui ZM; Zhang J; Huang Y
    Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
    Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
    Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12.
    Inngjerdingen M; Rolstad B; Ryan JC
    J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXC chemokine receptor 4 expression and stromal cell-derived factor-1alpha-induced chemotaxis in CD4+ T lymphocytes are regulated by interleukin-4 and interleukin-10.
    Jinquan T; Quan S; Jacobi HH; Madsen HO; Glue C; Skov PS; Malling HJ; Poulsen LK
    Immunology; 2000 Mar; 99(3):402-10. PubMed ID: 10712670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
    Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
    J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cDNA and genomic sequences encoding a canine chemokine receptor, CXCR4 and its ligand CXCL12.
    Tsuchida S; Kagi A; Takahashi T
    Vet Immunol Immunopathol; 2007 Apr; 116(3-4):219-25. PubMed ID: 17316828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL14 Inhibits Insulin Secretion Independently of CXCR4 or CXCR7 Receptor Activation or cAMP Inhibition.
    Atanes P; Hawkes RG; Olaniru OE; Ruz-Maldonado I; Amisten S; Persaud SJ
    Cell Physiol Biochem; 2019; 52(4):879-892. PubMed ID: 30958662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45.
    Fernandis AZ; Cherla RP; Ganju RK
    J Biol Chem; 2003 Mar; 278(11):9536-43. PubMed ID: 12519755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.